Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ainsley Wingard

Physician Assistant Spartanburg, SC Physician Assistant

NPI 1205305281 CMS profile 10625674

101 E Wood St, Spartanburg, SC 29303

Open in the dashboard

General payments

$16,253

789 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ainsley Wingard of Spartanburg, SC is reported in the CMS Open Payments database as having received $16,253 across 789 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,051 121
2024 General $3,278 178
2023 General $4,298 191
2022 General $3,630 171
2021 General $2,996 128

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ainsley Wingard
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Ainsley Wingard were reported at $2,051. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Ainsley Wingard Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $2,996 $132 $37–$438 $132
2022 $3,630 $155 $48–$522 $149
2023 $4,298 $167 $52–$557 $160
2024 $3,278 $178 $55–$600 $164
2025 $2,051 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,583 143 payments
  2. Lilly USA, LLC $1,695 71 payments
  3. Janssen Biotech, Inc. $1,544 63 payments
  4. Incyte Corporation $1,300 73 payments
  5. Sun Pharmaceutical Industries Inc. $1,179 62 payments
  6. Pfizer Inc. $882 45 payments
  7. UCB, Inc. $686 34 payments
  8. Novartis Pharmaceuticals Corporation $682 33 payments
  9. Genzyme Corporation $574 23 payments
  10. E.R. Squibb & Sons, L.L.C. $534 28 payments
  11. Other $4,594 214 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $14,888 772 payments
  2. Education $1,242 16 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $123 1 payment
Products named General payments · program years 2021–2025
  1. TREMFYA $1,664 52 payments
  2. RINVOQ $1,215 61 payments
  3. OPZELURA $1,201 72 payments
  4. TALTZ $1,194 59 payments
  5. SKYRIZI $971 53 payments
  6. DUPIXENT $902 34 payments
  7. CIBINQO $813 40 payments
  8. SOTYKTU $534 28 payments
  9. ILUMYA $529 38 payments
  10. OLUMIANT $447 19 payments
  11. Other $7,407 425 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

789 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record